ethyl 4-(4-methoxyphenyl)-6-methyl-2-(methylthio)pyrimidine-5-carboxylate | 1236204-32-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: ethyl 4-(4-methoxyphenyl)-6-methyl-2-(methylthio)pyrimidine-5-carboxylate
• 英文别名: ethyl 4-(4-methoxyphenyl)-6-methyl-2-methylsulfanylpyrimidine-5-carboxylate
• CAS: 1236204-32-2
• 化学式: C₁₆H₁₈N₂O₃S
• 分子量: 318.397
• InChiKey: KJRUCRXKWIUCAB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  86.6
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  ethyl 4-(4-methoxyphenyl)-6-methyl-2-(methylthio)pyrimidine-5-carboxylate 在 ammonium hydroxide 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 12.0h， 生成 4-(4-methoxyphenylamino)-6-methyl(methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one
  参考文献：
  名称：

  [EN] KINASE INHIBITORS
  [FR] INHIBITEURS DE KINASES

  摘要：

  公开号：

  WO2011053861A8
• 作为产物：
  描述：

  Ethyl 6-(4-methoxyphenyl)-4-methyl-2-(methylsulfanyl)-1,6-dihydropyrimidine-5-carboxylate 在 碘苯二乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 1.0h， 以79%的产率得到ethyl 4-(4-methoxyphenyl)-6-methyl-2-(methylthio)pyrimidine-5-carboxylate
  参考文献：
  名称：

  使用（二乙酰氧基碘）苯进行4-取代-1,4-二氢嘧啶的轻度和高效氧化芳构化

  摘要：

  4-烷基或芳基-1,4-二氢嘧啶很容易在温和的反应条件下被（二乙酰氧基碘）苯氧化为相应的嘧啶衍生物，收率很好。J.杂环化​​学。（2010）。

  DOI：

  10.1002/jhet.389

文献信息

• Mild and efficient oxidative aromatization of 4-substituted-1,4-dihydropyrimidines using (diacetoxyiodo)benzene
  作者：Nandkishor N. Karade、Sumit V. Gampawar、Nilesh P. Tale、Sanjay B. Kedar

  DOI：10.1002/jhet.389

  日期：——

  4‐Alkyl or aryl‐1,4‐dihydropyrimidines were readily oxidized by (diacetoxyiodo)benzene under mild reaction conditions to the corresponding pyrimidine derivatives in good to excellent yields. J. Heterocyclic Chem., (2010).

  4-烷基或芳基-1,4-二氢嘧啶很容易在温和的反应条件下被（二乙酰氧基碘）苯氧化为相应的嘧啶衍生物，收率很好。J.杂环化​​学。（2010）。
• Synthesis of 2-substituted pyrimidines and benzoxazoles via a visible-light-driven organocatalytic aerobic oxidation: enhancement of the reaction rate and selectivity by a base
  作者：Lin Wang、Zhi-Gang Ma、Xiao-Jing Wei、Qing-Yuan Meng、Deng-Tao Yang、Shao-Fu Du、Zi-Fei Chen、Li-Zhu Wu、Qiang Liu

  DOI：10.1039/c4gc00337c

  日期：——

  An efficient visible-light-driven photocatalytic oxidation of various 2-substituted dihydropyrimidines and phenolic imines has been achieved using an organic photocatalyst eosin Y bis(tetrabutyl ammonium salt) (TBA-eosin Y) and inexpensive oxidant molecular oxygen. With the aid of a base, significantly enhanced photoinduced electron transfer from substrates dihydropyrimidines or phenolic imines to the excited state of TBA-eosin Y has enabled the aerobic oxidation to yield 2-(methylthio)pyrimidines or 2-arylbenzoxazoles selectively.

  利用有机光催化剂藻红Y双(四丁基铵盐)(TBA-藻红Y)和廉价氧化剂分子氧，已经实现了各种2-取代二氢嘧啶和酚亚胺的高效可见光驱动光催化氧化反应。在碱的辅助下，从底物二氢嘧啶或酚亚胺到TBA-藻红Y激发态的显著增强的光诱导电子转移，使得空气氧化能够选择性地生成2-(甲硫基)嘧啶或2-芳基苯并噁唑。
• KINASE INHIBITORS
  申请人：Kim Hong Woo

  公开号：US20110269739A1

  公开（公告）日：2011-11-03

  The present invention provides a new group of protein kinase inhibitors, pyrido[4,3,-d]pyrimidin-5-one derivatives, and pharmaceutically acceptable salts thereof that are useful for intreating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrido[4,3,-d]pyrimidin-5-one derivatives.

  本发明提供了一种新的蛋白激酶抑制剂，即吡啶并[4,3,-d]嘧啶-5-酮衍生物及其药学上可接受的盐，可用于治疗细胞增殖性疾病和紊乱，如癌症、自身免疫疾病、感染、心血管疾病和神经退行性疾病和紊乱。本发明提供了合成和给药蛋白激酶抑制剂化合物的方法。本发明还提供了包含至少一种蛋白激酶抑制剂化合物和其药学上可接受的载体、稀释剂或赋形剂的药物制剂。本发明还提供在吡啶并[4,3,-d]嘧啶-5-酮衍生物合成过程中产生的有用中间体。
• Kinase inhibitors
  申请人：Kim Hong Woo

  公开号：US08404677B2

  公开（公告）日：2013-03-26

  The present invention provides a new group of protein kinase inhibitors, pyrido[4,3,-d]pyrimidin-5-one derivatives, and pharmaceutically acceptable salts thereof that are useful for intreating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrido[4,3,-d]pyrimidin-5-one derivatives.

  本发明提供了一种新型的蛋白激酶抑制剂，即吡啶并[4,3,-d]嘧啶-5-酮衍生物及其药学上可接受的盐，用于治疗细胞增殖性疾病和疾病，如癌症、自身免疫性疾病、感染、心血管疾病和神经退行性疾病。本发明提供了合成和给药蛋白激酶抑制剂化合物的方法。本发明还提供了包含至少一种蛋白激酶抑制剂化合物和药学上可接受的载体、稀释剂或赋形剂的药物制剂。本发明还提供在合成吡啶并[4,3,-d]嘧啶-5-酮衍生物期间生成的有用中间体。
• Efficient aerobic oxidative dehydrogenation of dihydropyrimidinones and dihydropyrimidines
  作者：Bing Han、Run-Feng Han、Yu-Wei Ren、Xiao-Yong Duan、Yi-Chuan Xu、Wei Zhang

  DOI：10.1016/j.tet.2011.05.105

  日期：2011.8

  4-Substituted dihydropyrimidinones and dihydropyrimidines were first efficient aerobic oxidized to the corresponding pyrimidinones and pyrimidines, respectively, in high yields by molecular oxygen in the presence of catalytic amount of N-hydroxyphthalimide (NHPI) and Co(OAc)(2) in a mild and environmental benign condition. (C) 2011 Elsevier Ltd. All rights reserved.